Stryker has reported $781 million in quarterly sales for its reconstructive business line, down 1.1 percent compared to the same quarter last year. Although the medical device company saw higher unit volumes, these gains were offset by unfavorable changes in price and foreign currency exchange rates. Stryker saw an overall sales gain of 1 percent totaling $2.1 billion for this quarter.
More Articles on Orthopedic Devices:
Johnson & Johnson Worldwide Medical Device, Diagnostics Sales Reach $7.1B
Brian McCollum to Lead Orthofix Spine Global Business Unit
Lanx Raises $8.7M to Boost Sales of Fusion System, Introduce New Products